APO Research
Talk to an analyst

APO RESEARCH · REPORT

Butorphanol

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Butorphanol Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025195 pages

Choose your research edition.

Industry ResearchButorphanol Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Butorphanol Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Butorphanol Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Butorphanol Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Butorphanol Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Butorphanol market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Butorphanol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Butorphanol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Butorphanol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Butorphanol is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Butorphanol include Zoetis, Merck KGaA, Mylan, Pfizer, Troy Laboratories Nz, Selectavet, Sanochemia Pharmazeutika, Richter Pharma Ag and Novex Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Butorphanol market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Butorphanol and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Butorphanol sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Butorphanol market size, projected growth trends, production technologies, key applications, and end-use industries.

Butorphanol Segment by Company

Zoetis

Merck KGaA

Mylan

Pfizer

Troy Laboratories Nz

Selectavet

Sanochemia Pharmazeutika

Richter Pharma Ag

Novex Pharma

Hikma Pharmaceuticals

Faunapharma

Dechra Pharmaceuticals

Bristol Myers Squibb

Boehringer Ingelheim Santé Animale

Ausrichter

Athanas Enterprise Private Limited

Apothecon Pharmaceuticals

Animedica

Butorphanol Segment by Type

Injection

Spray

Tablet

Butorphanol Segment by Application

Human

Veterinary

Butorphanol Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Butorphanol market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Butorphanol and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Butorphanol.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Butorphanol market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Butorphanol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Butorphanol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Butorphanol in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Butorphanol Industry Trends Table 2. Butorphanol Industry Drivers Table 3. Butorphanol Industry Opportunities and Challenges Table 4. Butorphanol Industry Restraints Table 5. Global Butorphanol Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Butorphanol Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Butorphanol Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Butorphanol Sales Market Share by Manufacturers Table 9. Global Butorphanol Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Butorphanol Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Butorphanol Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Butorphanol Manufacturers, Product Type & Application Table 13. Global Butorphanol Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Butorphanol by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Injection Table 17. Major Manufacturers of Spray Table 18. Major Manufacturers of Tablet Table 19. Global Butorphanol Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Butorphanol Sales by Type (2021-2026) & (K Units) Table 21. Global Butorphanol Sales by Type (2027-2032) & (K Units) Table 22. Global Butorphanol Sales Market Share by Type (2021-2026) Table 23. Global Butorphanol Sales Market Share by Type (2027-2032) Table 24. Global Butorphanol Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Butorphanol Revenue by Type (2021-2026) & (K Units) Table 26. Global Butorphanol Revenue by Type (2027-2032) & (K Units) Table 27. Global Butorphanol Revenue Market Share by Type (2021-2026) Table 28. Global Butorphanol Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Human Table 30. Major Manufacturers of Veterinary Table 31. Global Butorphanol Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Butorphanol Sales by Application (2021-2026) & (K Units) Table 33. Global Butorphanol Sales by Application (2027-2032) & (K Units) Table 34. Global Butorphanol Sales Market Share by Application (2021-2026) Table 35. Global Butorphanol Sales Market Share by Application (2027-2032) Table 36. Global Butorphanol Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Butorphanol Revenue by Application (2021-2026) & (K Units) Table 38. Global Butorphanol Revenue by Application (2027-2032) & (K Units) Table 39. Global Butorphanol Revenue Market Share by Application (2021-2026) Table 40. Global Butorphanol Revenue Market Share by Application (2027-2032) Table 41. Global Butorphanol Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Butorphanol Sales by Region (2021-2026) & (K Units) Table 43. Global Butorphanol Sales Market Share by Region (2021-2026) Table 44. Global Butorphanol Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Butorphanol Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Butorphanol Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Butorphanol Sales by Country (2021-2026) & (K Units) Table 48. North America Butorphanol Sales by Country (2027-2032) & (K Units) Table 49. Europe Butorphanol Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Butorphanol Sales by Country (2021-2026) & (K Units) Table 51. Europe Butorphanol Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Butorphanol Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Butorphanol Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Butorphanol Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Butorphanol Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Butorphanol Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Butorphanol Sales by Country (2027-2032) & (K Units) Table 58. Global Butorphanol Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Butorphanol Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Butorphanol Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Butorphanol Revenue Market Share by Region (2021-2026) Table 62. Global Butorphanol Revenue Market Share by Region (2027-2032) Table 63. Zoetis Company Information Table 64. Zoetis Business Overview Table 65. Zoetis Butorphanol Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Zoetis Butorphanol Product Portfolio Table 67. Zoetis Recent Development Table 68. Merck KGaA Company Information Table 69. Merck KGaA Business Overview Table 70. Merck KGaA Butorphanol Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Merck KGaA Butorphanol Product Portfolio Table 72. Merck KGaA Recent Development Table 73. Mylan Company Information Table 74. Mylan Business Overview Table 75. Mylan Butorphanol Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Mylan Butorphanol Product Portfolio Table 77. Mylan Recent Development Table 78. Pfizer Company Information Table 79. Pfizer Business Overview Table 80. Pfizer Butorphanol Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Pfizer Butorphanol Product Portfolio Table 82. Pfizer Recent Development Table 83. Troy Laboratories Nz Company Information Table 84. Troy Laboratories Nz Business Overview Table 85. Troy Laboratories Nz Butorphanol Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Troy Laboratories Nz Butorphanol Product Portfolio Table 87. Troy Laboratories Nz Recent Development Table 88. Selectavet Company Information Table 89. Selectavet Business Overview Table 90. Selectavet Butorphanol Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Selectavet Butorphanol Product Portfolio Table 92. Selectavet Recent Development Table 93. Sanochemia Pharmazeutika Company Information Table 94. Sanochemia Pharmazeutika Business Overview Table 95. Sanochemia Pharmazeutika Butorphanol Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Sanochemia Pharmazeutika Butorphanol Product Portfolio Table 97. Sanochemia Pharmazeutika Recent Development Table 98. Richter Pharma Ag Company Information Table 99. Richter Pharma Ag Business Overview Table 100. Richter Pharma Ag Butorphanol Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Richter Pharma Ag Butorphanol Product Portfolio Table 102. Richter Pharma Ag Recent Development Table 103. Novex Pharma Company Information Table 104. Novex Pharma Business Overview Table 105. Novex Pharma Butorphanol Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Novex Pharma Butorphanol Product Portfolio Table 107. Novex Pharma Recent Development Table 108. Hikma Pharmaceuticals Company Information Table 109. Hikma Pharmaceuticals Business Overview Table 110. Hikma Pharmaceuticals Butorphanol Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Hikma Pharmaceuticals Butorphanol Product Portfolio Table 112. Hikma Pharmaceuticals Recent Development Table 113. Faunapharma Company Information Table 114. Faunapharma Business Overview Table 115. Faunapharma Butorphanol Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Faunapharma Butorphanol Product Portfolio Table 117. Faunapharma Recent Development Table 118. Dechra Pharmaceuticals Company Information Table 119. Dechra Pharmaceuticals Business Overview Table 120. Dechra Pharmaceuticals Butorphanol Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Dechra Pharmaceuticals Butorphanol Product Portfolio Table 122. Dechra Pharmaceuticals Recent Development Table 123. Bristol Myers Squibb Company Information Table 124. Bristol Myers Squibb Business Overview Table 125. Bristol Myers Squibb Butorphanol Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Bristol Myers Squibb Butorphanol Product Portfolio Table 127. Bristol Myers Squibb Recent Development Table 128. Boehringer Ingelheim Santé Animale Company Information Table 129. Boehringer Ingelheim Santé Animale Business Overview Table 130. Boehringer Ingelheim Santé Animale Butorphanol Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Boehringer Ingelheim Santé Animale Butorphanol Product Portfolio Table 132. Boehringer Ingelheim Santé Animale Recent Development Table 133. Ausrichter Company Information Table 134. Ausrichter Business Overview Table 135. Ausrichter Butorphanol Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Ausrichter Butorphanol Product Portfolio Table 137. Ausrichter Recent Development Table 138. Athanas Enterprise Private Limited Company Information Table 139. Athanas Enterprise Private Limited Business Overview Table 140. Athanas Enterprise Private Limited Butorphanol Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Athanas Enterprise Private Limited Butorphanol Product Portfolio Table 142. Athanas Enterprise Private Limited Recent Development Table 143. Apothecon Pharmaceuticals Company Information Table 144. Apothecon Pharmaceuticals Business Overview Table 145. Apothecon Pharmaceuticals Butorphanol Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Apothecon Pharmaceuticals Butorphanol Product Portfolio Table 147. Apothecon Pharmaceuticals Recent Development Table 148. Animedica Company Information Table 149. Animedica Business Overview Table 150. Animedica Butorphanol Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Animedica Butorphanol Product Portfolio Table 152. Animedica Recent Development Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. Butorphanol Distributors List Table 156. Butorphanol Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Butorphanol Product Image Figure 2. Global Butorphanol Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Butorphanol Market Size (2021-2032) & (US$ Million) Figure 4. Global Butorphanol Sales (2021-2032) & (K Units) Figure 5. Global Butorphanol Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Butorphanol Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Injection Image Figure 9. Spray Image Figure 10. Tablet Image Figure 11. Global Butorphanol Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Butorphanol Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Butorphanol Sales Market Share by Type (2021-2032) Figure 14. Global Butorphanol Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Butorphanol Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Butorphanol Revenue Market Share by Type (2021-2032) Figure 17. Human Image Figure 18. Veterinary Image Figure 19. Global Butorphanol Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Butorphanol Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Butorphanol Sales Market Share by Application (2021-2032) Figure 22. Global Butorphanol Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Butorphanol Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Butorphanol Revenue Market Share by Application (2021-2032) Figure 25. North America Butorphanol Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Butorphanol Sales Market Share by Country (2021-2032) Figure 27. U.S. Butorphanol Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Butorphanol Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Butorphanol Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Butorphanol Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Butorphanol Sales Market Share by Country (2021-2032) Figure 32. Germany Butorphanol Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Butorphanol Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Butorphanol Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Butorphanol Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Butorphanol Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Butorphanol Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Butorphanol Sales Market Share by Country (2021-2032) Figure 39. China Butorphanol Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Butorphanol Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Butorphanol Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Butorphanol Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Butorphanol Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Butorphanol Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Butorphanol Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Butorphanol Sales Market Share by Country (2021-2032) Figure 47. Brazil Butorphanol Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Butorphanol Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Butorphanol Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Butorphanol Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Butorphanol Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Butorphanol Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Butorphanol Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Butorphanol Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Butorphanol Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Butorphanol Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Butorphanol Revenue (2021-2032) & (US$ Million) Figure 58. North America Butorphanol Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Butorphanol Revenue (2021-2032) & (US$ Million) Figure 60. Europe Butorphanol Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Butorphanol Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Butorphanol Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Butorphanol Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Butorphanol Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Butorphanol Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Butorphanol Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Spray
  • Tablet
Applications
  • Human
  • Veterinary
Companies covered
  • Zoetis
  • Merck KGaA
  • Mylan
  • Pfizer
  • Troy Laboratories Nz
  • Selectavet
  • Sanochemia Pharmazeutika
  • Richter Pharma Ag
  • Novex Pharma
  • Hikma Pharmaceuticals
  • Faunapharma
  • Dechra Pharmaceuticals
  • Bristol Myers Squibb
  • Boehringer Ingelheim Santé Animale
  • Ausrichter
  • Athanas Enterprise Private Limited
  • Apothecon Pharmaceuticals
  • Animedica

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Butorphanol Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Butorphanol Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Butorphanol Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Butorphanol Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Butorphanol Market Dynamics
  1. 2.1 Butorphanol Industry Trends
  2. 2.2 Butorphanol Industry Drivers
  3. 2.3 Butorphanol Industry Opportunities and Challenges
  4. 2.4 Butorphanol Industry Restraints
3 Butorphanol Market by Manufacturers
  1. 3.1 Global Butorphanol Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Butorphanol Sales by Manufacturers (2021-2026)
  3. 3.3 Global Butorphanol Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Butorphanol Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Butorphanol Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Butorphanol Manufacturers, Product Type & Application
  7. 3.7 Global Butorphanol Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Butorphanol Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Butorphanol Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Butorphanol Tier 1, Tier 2, and Tier 3
4 Butorphanol Market by Type
  1. 4.1 Butorphanol Type Introduction
  2. 4.1.1 Injection
  3. 4.1.2 Spray
  4. 4.1.3 Tablet
  5. 4.2 Global Butorphanol Sales by Type
  6. 4.2.1 Global Butorphanol Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Butorphanol Sales by Type (2021-2032)
  8. 4.2.3 Global Butorphanol Sales Market Share by Type (2021-2032)
  9. 4.3 Global Butorphanol Revenue by Type
  10. 4.3.1 Global Butorphanol Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Butorphanol Revenue by Type (2021-2032)
  12. 4.3.3 Global Butorphanol Revenue Market Share by Type (2021-2032)
5 Butorphanol Market by Application
  1. 5.1 Butorphanol Application Introduction
  2. 5.1.1 Human
  3. 5.1.2 Veterinary
  4. 5.2 Global Butorphanol Sales by Application
  5. 5.2.1 Global Butorphanol Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Butorphanol Sales by Application (2021-2032)
  7. 5.2.3 Global Butorphanol Sales Market Share by Application (2021-2032)
  8. 5.3 Global Butorphanol Revenue by Application
  9. 5.3.1 Global Butorphanol Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Butorphanol Revenue by Application (2021-2032)
  11. 5.3.3 Global Butorphanol Revenue Market Share by Application (2021-2032)
6 Global Butorphanol Sales by Region
  1. 6.1 Global Butorphanol Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Butorphanol Sales by Region (2021-2032)
  3. 6.2.1 Global Butorphanol Sales by Region (2021-2026)
  4. 6.2.2 Global Butorphanol Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Butorphanol Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Butorphanol Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Butorphanol Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Butorphanol Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Butorphanol Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Butorphanol Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Butorphanol Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Butorphanol Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Butorphanol Revenue by Region
  1. 7.1 Global Butorphanol Revenue by Region
  2. 7.1.1 Global Butorphanol Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Butorphanol Revenue by Region (2021-2026)
  4. 7.1.3 Global Butorphanol Revenue by Region (2027-2032)
  5. 7.1.4 Global Butorphanol Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Butorphanol Revenue (2021-2032)
  8. 7.2.2 North America Butorphanol Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Butorphanol Revenue (2021-2032)
  11. 7.3.2 Europe Butorphanol Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Butorphanol Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Butorphanol Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Butorphanol Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Butorphanol Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis
  2. 8.1.1 Zoetis Company Information
  3. 8.1.2 Zoetis Business Overview
  4. 8.1.3 Zoetis Butorphanol Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Butorphanol Product Portfolio
  6. 8.1.5 Zoetis Recent Developments
  7. 8.2 Merck KGaA
  8. 8.2.1 Merck KGaA Company Information
  9. 8.2.2 Merck KGaA Business Overview
  10. 8.2.3 Merck KGaA Butorphanol Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Merck KGaA Butorphanol Product Portfolio
  12. 8.2.5 Merck KGaA Recent Developments
  13. 8.3 Mylan
  14. 8.3.1 Mylan Company Information
  15. 8.3.2 Mylan Business Overview
  16. 8.3.3 Mylan Butorphanol Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Mylan Butorphanol Product Portfolio
  18. 8.3.5 Mylan Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Butorphanol Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Butorphanol Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 Troy Laboratories Nz
  26. 8.5.1 Troy Laboratories Nz Company Information
  27. 8.5.2 Troy Laboratories Nz Business Overview
  28. 8.5.3 Troy Laboratories Nz Butorphanol Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Troy Laboratories Nz Butorphanol Product Portfolio
  30. 8.5.5 Troy Laboratories Nz Recent Developments
  31. 8.6 Selectavet
  32. 8.6.1 Selectavet Company Information
  33. 8.6.2 Selectavet Business Overview
  34. 8.6.3 Selectavet Butorphanol Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Selectavet Butorphanol Product Portfolio
  36. 8.6.5 Selectavet Recent Developments
  37. 8.7 Sanochemia Pharmazeutika
  38. 8.7.1 Sanochemia Pharmazeutika Company Information
  39. 8.7.2 Sanochemia Pharmazeutika Business Overview
  40. 8.7.3 Sanochemia Pharmazeutika Butorphanol Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sanochemia Pharmazeutika Butorphanol Product Portfolio
  42. 8.7.5 Sanochemia Pharmazeutika Recent Developments
  43. 8.8 Richter Pharma Ag
  44. 8.8.1 Richter Pharma Ag Company Information
  45. 8.8.2 Richter Pharma Ag Business Overview
  46. 8.8.3 Richter Pharma Ag Butorphanol Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Richter Pharma Ag Butorphanol Product Portfolio
  48. 8.8.5 Richter Pharma Ag Recent Developments
  49. 8.9 Novex Pharma
  50. 8.9.1 Novex Pharma Company Information
  51. 8.9.2 Novex Pharma Business Overview
  52. 8.9.3 Novex Pharma Butorphanol Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Novex Pharma Butorphanol Product Portfolio
  54. 8.9.5 Novex Pharma Recent Developments
  55. 8.10 Hikma Pharmaceuticals
  56. 8.10.1 Hikma Pharmaceuticals Company Information
  57. 8.10.2 Hikma Pharmaceuticals Business Overview
  58. 8.10.3 Hikma Pharmaceuticals Butorphanol Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Hikma Pharmaceuticals Butorphanol Product Portfolio
  60. 8.10.5 Hikma Pharmaceuticals Recent Developments
  61. 8.11 Faunapharma
  62. 8.11.1 Faunapharma Company Information
  63. 8.11.2 Faunapharma Business Overview
  64. 8.11.3 Faunapharma Butorphanol Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Faunapharma Butorphanol Product Portfolio
  66. 8.11.5 Faunapharma Recent Developments
  67. 8.12 Dechra Pharmaceuticals
  68. 8.12.1 Dechra Pharmaceuticals Company Information
  69. 8.12.2 Dechra Pharmaceuticals Business Overview
  70. 8.12.3 Dechra Pharmaceuticals Butorphanol Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Dechra Pharmaceuticals Butorphanol Product Portfolio
  72. 8.12.5 Dechra Pharmaceuticals Recent Developments
  73. 8.13 Bristol Myers Squibb
  74. 8.13.1 Bristol Myers Squibb Company Information
  75. 8.13.2 Bristol Myers Squibb Business Overview
  76. 8.13.3 Bristol Myers Squibb Butorphanol Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Bristol Myers Squibb Butorphanol Product Portfolio
  78. 8.13.5 Bristol Myers Squibb Recent Developments
  79. 8.14 Boehringer Ingelheim Santé Animale
  80. 8.14.1 Boehringer Ingelheim Santé Animale Company Information
  81. 8.14.2 Boehringer Ingelheim Santé Animale Business Overview
  82. 8.14.3 Boehringer Ingelheim Santé Animale Butorphanol Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Boehringer Ingelheim Santé Animale Butorphanol Product Portfolio
  84. 8.14.5 Boehringer Ingelheim Santé Animale Recent Developments
  85. 8.15 Ausrichter
  86. 8.15.1 Ausrichter Company Information
  87. 8.15.2 Ausrichter Business Overview
  88. 8.15.3 Ausrichter Butorphanol Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Ausrichter Butorphanol Product Portfolio
  90. 8.15.5 Ausrichter Recent Developments
  91. 8.16 Athanas Enterprise Private Limited
  92. 8.16.1 Athanas Enterprise Private Limited Company Information
  93. 8.16.2 Athanas Enterprise Private Limited Business Overview
  94. 8.16.3 Athanas Enterprise Private Limited Butorphanol Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Athanas Enterprise Private Limited Butorphanol Product Portfolio
  96. 8.16.5 Athanas Enterprise Private Limited Recent Developments
  97. 8.17 Apothecon Pharmaceuticals
  98. 8.17.1 Apothecon Pharmaceuticals Company Information
  99. 8.17.2 Apothecon Pharmaceuticals Business Overview
  100. 8.17.3 Apothecon Pharmaceuticals Butorphanol Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Apothecon Pharmaceuticals Butorphanol Product Portfolio
  102. 8.17.5 Apothecon Pharmaceuticals Recent Developments
  103. 8.18 Animedica
  104. 8.18.1 Animedica Company Information
  105. 8.18.2 Animedica Business Overview
  106. 8.18.3 Animedica Butorphanol Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Animedica Butorphanol Product Portfolio
  108. 8.18.5 Animedica Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Butorphanol Value Chain Analysis
  2. 9.1.1 Butorphanol Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Butorphanol Production Mode & Process
  6. 9.2 Butorphanol Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Butorphanol Distributors
  9. 9.2.3 Butorphanol Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst